GADD45A Expression is Correlated with Patient Prognosis in Esophageal Cancer

Overview

Journal Oncol Lett

Specialty Oncology

Date 2016 Feb 13

PMID 26870203

Citations 9

Authors

Hideyuki Ishiguro

Masahiro Kimura

Hiroki Takahashi

Tatsuya Tanaka

Koji Mizoguchi

Hiromitsu Takeyama

Affiliations

Soon will be listed here.

Abstract

The prognosis of patients with esophageal cancer remains poor, and the tumor-node-metastasis classification system is not sufficient for predicting patient prognoses. Therefore, the identification of novel predictive markers for esophageal cancer is required. The present study investigated the clinicopathological significance of growth arrest and DNA damage-inducible 45α (GADD45A) and p53 in resectable esophageal squamous cell carcinoma (ESCC). The study consisted of 62 patients with esophageal cancer who underwent surgery between 2001 and 2007. The expression of the gene product (GADD45A) and the p53 protein was analyzed by immunohistochemistry. The correlations among GADD45A expression, clinicopathological factors and prognosis were then analyzed in the patients with ESCC. GADD45A and p53 were expressed in 56.5% (35/62) and 48.4% (30/62) of patients, respectively. The expression of GADD45A did not show a marked correlation with that of p53. However, GADD45A expression correlated with pathological stage (stage 0-I vs. stages II-IV; P=0.014) and did not correlate with the tumor (T) or node (N) status. Furthermore, patients who were positive for GADD45A exhibited a significantly higher survival rate than those who were negative for GADD45A (log-rank test, P=0.009). Multivariate analysis indicated that T status, N status and GADD45A expression were significant variables predicting survival (hazard ratio, 2.486; 95% confidence interval, 1.168-5.290; P=0.018). Overall, GADD45A expression significantly affected the survival of patients with ESCC, and the reduced expression of GADD45A was correlated with a poor prognosis following curative surgery in these patients.

Citing Articles

Non-coding RNA mediates endoplasmic reticulum stress-induced apoptosis in heart disease.

Fan M, Zhang J, Zeng L, Wang D, Chen J, Xi X Heliyon. 2023; 9(5):e16246.

PMID: 37251826 PMC: 10209419. DOI: 10.1016/j.heliyon.2023.e16246.

Reactivation of mutant p53 in esophageal squamous cell carcinoma by isothiocyanate inhibits tumor growth.

Guan L, Yang Y, Lu Y, Chen Y, Luo X, Xin D Front Pharmacol. 2023; 14:1141420.

PMID: 37168998 PMC: 10164965. DOI: 10.3389/fphar.2023.1141420.

Polymorphisms within DIO2 and GADD45A genes increase the risk of liver disease progression in chronic hepatitis b carriers.

Rybicka M, Verrier E, Baumert T, Bielawski K Sci Rep. 2023; 13(1):6124.

PMID: 37059745 PMC: 10104815. DOI: 10.1038/s41598-023-32753-8.

Lenvatinib inhibits intrahepatic cholangiocarcinoma via Gadd45a-mediated cell cycle arrest.

Yan X, Wang D, Ning Z, Meng Z Discov Oncol. 2023; 14(1):26.

PMID: 36821012 PMC: 9950313. DOI: 10.1007/s12672-023-00631-4.

GADD45 in Stress Signaling, Cell Cycle Control, and Apoptosis.

Humayun A, Fornace Jr A Adv Exp Med Biol. 2022; 1360:1-22.

PMID: 35505159 DOI: 10.1007/978-3-030-94804-7_1.

References

Kuerbitz S, Plunkett B, Walsh W, Kastan M . Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992; 89(16):7491-5. PMC: 49736. DOI: 10.1073/pnas.89.16.7491. View

Girard L, Zochbauer-Muller S, Virmani A, Gazdar A, Minna J . Genome-wide allelotyping of lung cancer identifies new regions of allelic loss, differences between small cell lung cancer and non-small cell lung cancer, and loci clustering. Cancer Res. 2000; 60(17):4894-906. View

Shibata Y, Haruki N, Kuwabara Y, Nishiwaki T, Kato J, Shinoda N . Expression of PTTG (pituitary tumor transforming gene) in esophageal cancer. Jpn J Clin Oncol. 2002; 32(7):233-7. DOI: 10.1093/jjco/hyf058. View

Zhu Q, Ren W, Korchin B, Lahat G, Dicker A, Lu Y . Soft tissue sarcoma cells are highly sensitive to AKT blockade: a role for p53-independent up-regulation of GADD45 alpha. Cancer Res. 2008; 68(8):2895-903. PMC: 4174465. DOI: 10.1158/0008-5472.CAN-07-6268. View

Yoshida T, Maeda A, Horinaka M, Shiraishi T, Nakata S, Wakada M . Quercetin induces gadd45 expression through a p53-independent pathway. Oncol Rep. 2005; 14(5):1299-303. View

Nishiwaki T, Daigo Y, Kawasoe T, Nakamura Y . Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer. 1999; 27(2):169-76. View

Hofler H, Langer R, Ott K, Keller G . Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tract. Recent Results Cancer Res. 2007; 176:33-6. DOI: 10.1007/978-3-540-46091-6_4. View

Itami A, Shimada Y, Watanabe G, Imamura M . Prognostic value of p27(Kip1) and CyclinD1 expression in esophageal cancer. Oncology. 1999; 57(4):311-7. DOI: 10.1159/000012067. View

Wang X, Zhan Q, Coursen J, Khan M, Kontny H, Yu L . GADD45 induction of a G2/M cell cycle checkpoint. Proc Natl Acad Sci U S A. 1999; 96(7):3706-11. PMC: 22358. DOI: 10.1073/pnas.96.7.3706. View

10.

Langer R, Specht K, Becker K, Ewald P, Bekesch M, Sarbia M . Association of pretherapeutic expression of chemotherapy-related genes with response to neoadjuvant chemotherapy in Barrett carcinoma. Clin Cancer Res. 2005; 11(20):7462-9. DOI: 10.1158/1078-0432.CCR-05-0042. View

11.

Jiang W, Zhang Y, Kahn S, Hollstein M, Santella R, Lu S . Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Proc Natl Acad Sci U S A. 1993; 90(19):9026-30. PMC: 47494. DOI: 10.1073/pnas.90.19.9026. View

12.

Liu W, Jiang X, Zhang M, Zhang Z . The relationship between HPV16 and expression of cyclooxygenase-2, P53 and their prognostic roles in esophageal squamous cell carcinoma. Eur J Gastroenterol Hepatol. 2009; 22(1):67-74. DOI: 10.1097/MEG.0b013e32832c7e76. View

13.

Papathanasiou M, Kerr N, ROBBINS J, MCBRIDE O, Alamo Jr I, Barrett S . Induction by ionizing radiation of the gadd45 gene in cultured human cells: lack of mediation by protein kinase C. Mol Cell Biol. 1991; 11(2):1009-16. PMC: 359769. DOI: 10.1128/mcb.11.2.1009-1016.1991. View

14.

Sugito N, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Kurehara H . RNASEN regulates cell proliferation and affects survival in esophageal cancer patients. Clin Cancer Res. 2006; 12(24):7322-8. DOI: 10.1158/1078-0432.CCR-06-0515. View

15.

Smith M, Chen I, Zhan Q, Bae I, Chen C, Gilmer T . Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen. Science. 1994; 266(5189):1376-80. DOI: 10.1126/science.7973727. View

16.

Marx J . New link found between p53 and DNA repair. Science. 1994; 266(5189):1321-2. DOI: 10.1126/science.7973719. View

17.

Kastan M, Zhan Q, El-Deiry W, Carrier F, Jacks T, Walsh W . A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia. Cell. 1992; 71(4):587-97. DOI: 10.1016/0092-8674(92)90593-2. View

18.

Harkin D, Bean J, Miklos D, Song Y, Truong V, Englert C . Induction of GADD45 and JNK/SAPK-dependent apoptosis following inducible expression of BRCA1. Cell. 1999; 97(5):575-86. DOI: 10.1016/s0092-8674(00)80769-2. View

19.

Santucci M, Barbieri E, Frezza G, Perrone A, Iacurti E, Galuppi A . Radiation-induced gadd45 expression correlates with clinical response to radiotherapy of cervical carcinoma. Int J Radiat Oncol Biol Phys. 2000; 46(2):411-6. DOI: 10.1016/s0360-3016(99)00459-9. View

20.

Amundson S, Myers T, Scudiero D, Kitada S, Reed J, Fornace Jr A . An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res. 2000; 60(21):6101-10. View